Press release
Cancer Vaccine Market: A Transformative Approach to Combatting Cancer
Cancer Vaccine Market
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2642
Key Drivers of Growth
The cancer vaccine market is being propelled by several critical factors. The rising incidence of cancer-estimated at approximately 10 million deaths worldwide in 2020, as reported by the World Health Organization-underscores the urgent need for effective treatments. The American Cancer Society reported nearly 1.9 million new cancer cases in the United States alone in 2022, emphasizing a growing patient population.
Moreover, personalized cancer vaccines designed to target specific mutations in cancer cells have shown promise in improving treatment efficacy. For example, Amazon's collaboration with Fred Hutchinson aims to develop personalized vaccines targeting breast cancer and melanoma.
Technological advancements also play a crucial role in market growth. Moderna's mRNA vaccines, which recently demonstrated a 44% reduction in the risk of disease recurrence in melanoma patients, highlight the potential of these innovative treatments to provide more effective and less toxic alternatives to traditional therapies like chemotherapy.
Market Challenges
Despite the positive trends, the market faces challenges. Side effects from cancer vaccines and their high costs may deter some patients from opting for these treatments. According to the National Cancer Institute, while radiation can be effective in killing cancer cells, it also poses various side effects that can complicate patient care.
Market Segmentation Insights
The global cancer vaccine market is segmented based on vaccine type, indication, and end use:
By Type:
Preventive Cancer Vaccines dominate the market, driven by vaccines like the Human Papillomavirus (HPV) and Hepatitis B vaccines, which protect against various cancers.
Therapeutic Cancer Vaccines are experiencing rapid growth, providing new hope for those already diagnosed with cancer.
By Indication:
The Cervical Cancer segment is projected to capture a significant market share, with increasing cases and recent product launches, such as India's first indigenous HPV vaccine, Cervavac.
The Lung Cancer segment, while growing, is doing so at a moderate pace, addressing a substantial number of cases globally.
By End Use:
The Hospitals segment is expected to lead the market due to the increasing number of patient admissions and specialized facilities required to handle and store cancer vaccines safely.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/cancer-vaccine-market
Cancer Vaccine Top Companies and Competitive Landscape
The global cancer vaccine market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective cancer vaccine solutions in the market.
Some major players included in the global cancer vaccine market report are:
AstraZeneca
Hoffmann-La Roche Ltd.
GSK
Sanofi
Moderna, Inc.
Bristol-Myers Squibb Company
Barinthus Biotherapeutics
Dendreon Pharmaceuticals LLC
Elicio Therapeutics
BioNTech SE
Cancer Vaccine Latest Industry Updates
On 11 September 2023, Moderna collaborate with Immatics to develop new cancer vaccine, which will be used mRNA technology to target cancer cells. This was done by using Immatics' data on tumor and normal tissue to identify new targets for cancer vaccines. Moderna's mRNA technology used to develop vaccines that target these targets. This collaboration is a positive development for the cancer vaccine market and for patients with cancer. It has the potential to lead to the development of new and more effective cancer vaccines.
On 5 January 2023, BioNTech announced its partnership with the UK government to provide personalized mRNA cancer immunotherapies. The partnership will provide BioNTech with access to the UK's healthcare system, which make it easier to bring its personalized mRNA cancer immunotherapies to market in the UK. This give patient with cancer in the UK access to new and potentially more effective treatment options. The vaccine is more likely to be effective than traditional cancer therapies, such as chemotherapy and radiation therapy, which are not personalized.
Purchase This Market Research Report - https://www.emergenresearch.com/select-license/2642
For the purpose of this report, Emergen Research has segmented the global cancer vaccine market on the basis of type, Indication, technology, end-use, and region:
Type Outlook (Revenue, USD Billion; 2019-2032)
Preventive Cancer Vaccine
Therapeutic Cancer Vaccine
Others
Indication Outlook (Revenue, USD Billion; 2019-2032)
Lung Cancer
Cervical Cancer
Prostate Cancer
Bladder Cancer
Others
Technology Outlook (Revenue, USD Billion; 2019-2032)
Recombinant Cancer Vaccines
Whole-cell Cancer Vaccines
Viral Vector and DNA Cancer Vaccines
Other Technologies
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Research Institute
Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Benelux
Russia
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
ASEAN Countries
Oceania
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
Israel
Turkey
South Africa
Rest of Middle East & Africa
Look Over transcripts provided by Emergen Research
Cancer Vaccine Market Size@ https://www.emergenresearch.com/industry-report/cancer-vaccine-market/market-size
Cancer Vaccine Market Share@ https://www.emergenresearch.com/industry-report/cancer-vaccine-market/market-share
Cancer Vaccine Market Trends@ https://www.emergenresearch.com/industry-report/cancer-vaccine-market/market-trends
Cancer Vaccine Regional Market Demand@ https://www.emergenresearch.com/industry-report/cancer-vaccine-market/regional-market-demand
Cancer Vaccine Market Analysis@ https://www.emergenresearch.com/industry-report/cancer-vaccine-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Vaccine Market: A Transformative Approach to Combatting Cancer here
News-ID: 3704574 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
